Showing 25–44 of 44 peptides in Weight Loss
An investigational peptide studied for cardiometabolic and weight-management applications.
- Skin, Hair & Beauty
- Weight Loss
A peptide studied for pigmentation and photoprotection.
- Alpha‑MSH analog studied for increasing skin pigmentation and photoprotection
- May help reduce sunburn risk by darkening skin through melanocortin receptor activation
- Investigated for potential effects on appetite and inflammation via melanocortin pathways
- Sexual Health
- Skin, Hair & Beauty
- +1
A melanocortin peptide researched for tanning and libido effects.
- Melanocortin analog researched for tanning and libido‑modulating effects
- May enhance sexual arousal and erectile function through central melanocortin signaling
- Investigated for appetite suppression and body‑weight modulation
- Muscle Recovery
- Sleep & Mood
- +1
An oral growth hormone secretagogue studied for GH stimulation.
- Oral growth hormone secretagogue researched for raising GH and IGF-1 levels
- May support increases in lean body mass, strength, and bone density in studies
- Investigated for enhancing sleep quality, recovery, and overall body composition
- Muscle Recovery
- Weight Loss
- +1
A refined GHRH analog for growth hormone stimulation.
- Stabilized GHRH analog studied for amplifying natural growth hormone pulses
- May support muscle gain, fat loss, and recovery when combined with GHRPs
- Investigated for preserving more physiologic GH secretion patterns
A mitochondrial peptide researched for metabolic health.
- Mitochondria-derived peptide researched for improving insulin sensitivity and glucose handling
- May enhance mitochondrial respiration and protect against metabolic and cardiac dysfunction
- Investigated for reducing weight gain and age-related metabolic decline in models
An oral non-peptide GLP-1 receptor agonist researched for obesity and diabetes.
A bioregulatory peptide researched for pancreatic support.
- Pancreatic bioregulatory peptide studied for supporting insulin and glucagon regulation
- May enhance pancreatic cell repair, enzyme production, and digestive efficiency
- Investigated for improving blood sugar control and metabolic health with aging
- Muscle Recovery
- Weight Loss
A high-purity growth factor studied for receptor binding.
- Long‑acting IGF‑1 analog researched for potent stimulation of muscle protein synthesis
- May enhance muscle hypertrophy, recovery, and connective‑tissue repair
- Investigated for improved nutrient partitioning and reduction of muscle wasting
A multi-receptor incretin agonist studied for metabolic control.
- Triple agonist of GLP‑1, GIP, and glucagon receptors studied for substantial weight loss
- May provide robust reductions in HbA1c and improvements in liver and cardiometabolic markers
- Investigated for obesity, type 2 diabetes, NASH, and related metabolic diseases
A GLP-1 receptor agonist primarily used for weight management and blood sugar control.
- GLP‑1 receptor agonist studied for substantial and sustained weight loss in obesity
- Improves glycemic control and reduces cardiovascular and metabolic risk factors
- Acts on appetite centers and slows gastric emptying to enhance satiety
- Muscle Recovery
- Sleep & Mood
- +1
A growth hormone releasing hormone analog.
- GHRH analog studied for stimulating endogenous growth hormone secretion
- May support lean body mass, recovery, and sleep quality in GH‑deficient states
- Investigated as a physiologic alternative to exogenous GH therapy
- Weight Loss
- Heart & Vascular Health
A metabolic peptide studied for energy expenditure.
- Selective thyroid hormone receptor‑beta agonist researched for increasing energy expenditure
- May improve lipid profiles, fatty liver parameters, and body composition in models
- Investigated for obesity and metabolic syndrome without classical hyperthyroid effects
An investigational peptide studied for multi-receptor metabolic and weight-control effects.
A dual-agonist peptide researched for potent obesity and metabolic control.
- Weight Loss
- Muscle Recovery
- +1
A stabilized GHRH analog studied for GH enhancement.
- GHRH analog studied for reducing visceral adipose tissue, especially in HIV‑associated lipodystrophy
- Increases endogenous GH and IGF‑1 while largely preserving insulin sensitivity
- Investigated for body‑composition improvement and cardiometabolic risk reduction
A monoamine reuptake inhibitor studied for weight loss.
- Triple monoamine reuptake inhibitor researched for robust appetite suppression and weight loss
- Increases synaptic dopamine, norepinephrine, and serotonin to enhance satiety signaling
- Investigated for preserving resting energy expenditure and limiting post‑diet weight regain
A hypothalamic peptide studied for thyroid axis regulation.
- Hypothalamic tripeptide studied for stimulating TSH release from the pituitary
- May support thyroid hormone production and metabolic regulation in deficiency states
- Investigated for diagnostic testing of pituitary–thyroid axis integrity
A dual incretin peptide studied for powerful metabolic regulation.
- Dual GIP/GLP‑1 receptor agonist researched for powerful glucose lowering and weight loss
- Improves beta‑cell function and insulin sensitivity beyond GLP‑1 agonists alone
- Investigated for type 2 diabetes, obesity, and cardiometabolic risk reduction
An experimental incretin-pathway peptide studied for weight and glucose control.